Related content

Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea

By Takasuna K.   Hagiwara T.   Watanabe K.   Onose S.   Yoshida S.   Kumazawa E.   Nagai E.   Kamataki T.  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 4, 2006-10 ,pp. : 494-503

Springer Publishing Company

Access to resources Recommend Favorite

Diarrhea associated with afatinib: an oral ErbB family blocker

By Yang James Chih-Hsin   Reguart Noemi   Barinoff Jana   Köhler Jens   Uttenreuther-Fischer Martina   Stammberger Uz   O'Brien Dennis   Wolf Jürgen   Cohen Ezra EW  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 6, 2013-06 ,pp. : 729-736

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of Oral Cavity Care in Preventing Stomatitis (Mucositis) in Cancer Chemotherapy

By Koshino Miki   Sakai Chie   Ogura Takafumi   Kawasaki Akiko   Fukuzato Fumiko   Miyazaki Yasuhiro  

Japanese Journal of Cancer and Chemotherapy, Vol. 36, Iss. 3, 2009-03 ,pp. : 447-451

Sunmedia

Access to resources Recommend Favorite

Effectiveness of palonosetron for preventing delayed chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy in patients with gastrointestinal cancer

By Murakami Michiyasu   Hashimoto Hiroki   Yamaguchi Kyohei   Yamaguchi Ikuko   Senba Shozo   Siraishi Takeshi  

Supportive Care in Cancer, Vol. 22, Iss. 4, 2014-04 ,pp. : 905-909

Springer Publishing Company

Access to resources Recommend Favorite

Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: A Korean Cancer Study Group Trial

By Kim Tae Won   Kang Won Ki   Chang Heung Moon   Park Joon Oh   Ryoo Baek Yeol   Ahn Jin Seok   Zang Dae Young   Lee Kyung Hee   Kang Yoon Koo   Kim Sung Rok   Kim Hoon-Kyo  

Acta Oncologica, Vol. 44, Iss. 3, 2005-05 ,pp. : 230-235

Informa Healthcare

Access to resources Recommend Favorite